CCL5 and cancer: For instance, it is revealed that osteopontin as a tumor-derived inflammatory cytokine promotes CA-MSCs to the secret high level of CCL5, which binds to its receptor (CCR5) on cancer cells to enhance cancer cells’ metastatic potential and MSCs’ ability to migrate to metastasis site (132, 167, 168).